Universal Corporation Limited

We wish all our partners and friends a Merry Christmas and a prosperous new year, looking forward to bigger and better in the new year #buykenyabuildKenya

#AMMTEC24 was the first event of its kind to bring so many African medicine manufacturers together from all regions of the continent, and across dose-forms of critical health commodities. A huge range of African medicine manufacturers were in attendance, covering pharmaceuticals, diagnostics, vaccines, and Active Pharmaceutical Ingredients (APIs). Thank you for your commitment to accelerating our industry!    Africure Pharmaceuticals Limited, Aspen Pharma Group, ATLANTIC LIFESCIENCES LTD, Biodeal Laboratories Limited, Chemical Process Technologies, Dawa Life Sciences, DEI Biopharma Ltd, Dinlas Pharma, Droga Pharma Pvt.Ltd.Co, Emzor Pharmaceutical Industries Ltd, Epharm Laboratories, EVA pharma, Innovative Pharmaceutical Biotech Limited, Katwaza Pharmaceuticals Industry, Kiara Health (Pty) Ltd, Kiara MedTech (Pty) Ltd, Kilitch Drugs India Ltd, Laboratory & Allied Ltd., Pharmakina SA, Pharmanova d.o.o., Laboratoire Pharmaceutique Phatkin, Piston Medical , Plus Five Pharmaceuticals, TruPharma, LLC, Universal Corporation Limited, Varichem Pharmaceuticals (Pvt). LTD, Yash Life Sciences and Zimbabwe Pharmaceuticals Pvt Ltd. (Zimpharm)    #AMMTEC24 #PublicHealthAfrica #MedicinesForAfrica #PharmaProductionAfrica

AMEX Healthcare learning journey part 1 today: our entire quality & pharma team visiting Universal corporation. Great insights from speaking with a local manufacturer of pharmaceuticals who is WHO prequalified- very impressive seeing quality made in Kenya! Special thanks to Palu Dhanani & Meer Dhanani and their team!

To all you Superheroes of Healthcare! Your expertise and compassion make a world of difference! Universal wishes you a Happy World Pharmacist Day!

A new Unitaid report shows how manufacturing antimalarials in Africa is critical to fighting #malaria. The report identifies opportunities for interventions that address the barriers to achieving scaled, cost-effective, sustainable and commercially viable manufacturing of antimalarials in Africa.   The new report also demonstrates how the antimalarial manufacturing value chain is already being nurtured in Africa, highlighting how MMV and Unitaid supported Kenya’s Universal Corporation Limited in becoming the first African manufacturer to gain WHO prequalification for medicines to prevent malaria in pregnant women and children.   Find out more about MMV’s activities to support local manufacturing and read the Unitaid report on our website: bit.ly/3Ul3Xlv

The PQM+ program, funded by USAID, supports three local pharmaceutical manufacturers in #Kenya on their path to WHO prequalification, a certification that ensures the safety, effectiveness, and quality of medicines. To strengthen the supply chain security of health products, PQM+ provides onsite technical assistance on product dossier compilation for neglected tropical disease treatment and maternal health medicines. #HealthSystems #NTDs Biodeal Laboratories Limited Tasa Pharma @Universal Corporation Limited

A child dies of malaria every minute... That is a frightful statistic, making this year’s theme of World Malaria Day ‘Accelerating the fight against malaria for a more equitable world’ of the highest priority. We need to combat this disease with every means at our disposal. 2023 has seen several promising developments, like the introduction in 13 countries of the new RTS,S vaccine as a standard immunization method, resulting in dramatic drops in child mortality. A 2nd vaccine, called R21, has recently been WHO approved and is expected to result in sufficient vaccine supply to meet demand. A total of 43 countries have graduated to being malaria free. These are inspiring and encouraging results, showing that global efforts are paying off. At the same time, there are new challenges endangering this progress. Climate change is posing a threat as the mosquitos prosper in our warmer world and could spread to other territories. Increased resistance of the mosquitos to the current insecticides and drugs is another one. Donors are investing in research and development of new treatment methods and alternative ways of prevention, like the next generation ITNs, insecticide treated bednets, that The Global Fund is now focusing procurement on. Another trend is the focus on local production. Africa accounts for 95% of malaria cases and deaths globally. Reliable access to quality-assured malaria treatment is crucial to reducing the impact of the disease. Locally produced and locally sourced pharmaceuticals will increase countries’ resilience to diseases. But there are few producers of quality-assured medicines in the region. As a result, Africa currently imports up to 80% of the pharmaceuticals it uses. Of the continent’s 375 medicine producers, only six manufacture drugs to World Health Organization (WHO) prequalification (PQ) standards. The rest are constrained by underinvestment, infrastructure limitations, or regulatory challenges, according to this insightful essay, jointly published by our client Medicines for Malaria Venture and our supplier Universal Corporation Limited, one of the few in Africa with WHO prequalification https://lnkd.in/e5wQKqiW. i+solutions is pleased to play a role in the pooled procurement of antimalarials for The Global Fund and also works with governments and implementors to procure antimalaria and preventive treatments and deliver them to thousands of patients in over 100 countries. #worldmalariaday #endmalaria

i+solutions strongly recognizes the role of regional suppliers in contributing to the public health environment and believes their success brings significant value to making quality affordable medicines more accessible to patients.   Since 2015, i+solutions has a strong partnership with Universal Corporation Limited, Kenya (Universal). Universal is one of few African manufacturers to have obtained WHO prequalification for its production site and several products. i+ procures cotrimoxazole and other essential medicines from Universal under it’s donor funded projects. Since recently, XS2Meds (www.xs2meds.org), a fully owned subsidiary of i+solutions, launched some of the Universal products to it’s private sector clients in East-Africa, which will further increase the use of locally produced products available on the continent.     In a recent conversation with Meer Dhanani, Business Development Manager at Universal, also responsible for new product launches, we discussed access to medicines through local production, its challenges, how critical it is for the self-sufficiency and self-reliance of the health care sector on the African continent. Meer gave us several insights on how African manufacturing differs slightly from Asian manufacturing and what is needed to scale up local production capacity.   Please read all about those insights here https://lnkd.in/g8Yay4GD.   Mitigating supply risk for the African continent is high on the public health agenda. Investments are needed to build up local supply capacity and make sure economies of scale start working in favor of African pharma companies.   i+solutions and Universal are jointly looking at more sustainable business, expansion of products and expansion of territories, driving their joint purpose of making quality affordable medicines available to all patients. #accesstomedicines #localproduction #supplychain #procurement

Taking place this week, Unitaid’s 2024 Industry Engagement Forum aims to support the increase of health product manufacturing in #Africa.     Industrializing African healthcare sectors will enhance health security on the continent and around the world, increase access to affordable health solutions and provide tailored medicines for regional needs. MMV has been working in partnership with African manufacturers to support them in meeting World Health Organization standards of Good Manufacturing Practice (GMP) and Prequalification, including Kenya’s Universal Corporation Limited, which has gained WHO prequalification for a medicine to prevent malaria in pregnant women and infants, and another to prevent malaria in children.     Visit MMV’s website to learn more about our work to strengthen local manufacturing in Africa: bit.ly/3Ul3Xlv 

Realizing the importance of local manufacturing will help the AU achieve its pledge to increase the share of vaccines, medicines, and diagnostics locally manufactured in Africa to 60% by 2040. #PharmaAfrica #AfricanPharmaceuticals #MedicineManufacturing #HealthcareAfrica #LocalProduction #AfricanMedicine #PharmaceuticalIndustry #HealthTechAfrica #RegionalManufacturing #MedicineAccess 11. #HealthForAll 12. #InvestInAfrica 13. #SustainableHealthcare 14. #PharmaceuticalInnovation